Risk factors for and mortality of extended-spectrum-β-lactamase- producing Klebsiella pneumoniae and Escherichia coli nosocomial bloodstream infections

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 51, Issue 4, 2009, Pages 211-216

  Superti, Silvana Vargas ^a   Augusti, Gustavo ^a   Zavascki, Alexandre Prehn ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Bacteremia; Bacterial; Bloodstream infection; Drug resistance; Escherichia coli; Extended spectrum beta lactamase; Klebsiella pneumoniae; Risk factors

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AZTREONAM; BETA LACTAM; BETA LACTAMASE INHIBITOR; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEFUROXIME AXETIL; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; CEPHAMYCIN DERIVATIVE; CIPROFLOXACIN; CLAVULANIC ACID; CLINDAMYCIN; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; UREIDOPENICILLIN DERIVATIVE; VANCOMYCIN;

ADULT; AGED; ARTICLE; BLOOD CULTURE; CONTROLLED STUDY; ENZYME SYNTHESIS; ESCHERICHIA COLI; FEMALE; HOSPITAL INFECTION; HUMAN; ISOLATION PROCEDURE; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; RISK FACTOR;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMASES; BRAZIL; CASE-CONTROL STUDIES; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; SURVIVAL RATE;

EID: 70349322677     PISSN: 00364665     EISSN: 16789946     Source Type: Journal    
DOI: 10.1590/S0036-46652009000400006     Document Type: Article

References (26)

1. BIEDENBACH, D.J.; MOET, G.J. & JONES, R.N. - Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002). Diagn. Microbiol. infect. Dis., 50: 59-69, 2004.
2. CHARLSON, M.E.; POMPEI, P.; ALES, K.L. & MACKENZIE, C.R. - A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis., 40: 373-383, 1987.
3. th Informational Supplement. CLSI Document M-100 S17).
4. CORDERY, R.J.; ROBERTS, C.H.; COOPER, S.J.; BELLINGHAN, G. & SHETTY, N. - Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome. J. Hosp. Infect., 68: 108-115, 2007.
5. D'AGATA, E.M. - Methodologic issues of case-control studies: a review of established and newly recognized limitations. Infect. Control Hosp. Epidem., 26: 338-341, 2005.
6. DU, B.; LONG, Y.; LIU, H. et al. - Extended-spectrum beta-lactamase- producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome. Intensive Care Med., 28: 1718-1723, 2002. (Pubitemid 35435472)
7. GALES, A.C.; BOLMSTRÖM, A.; SAMPAIO, J.; JONES, R.N. & SADER, H.S. - Antimicrobial susceptibility of Klebsiella pneumoniae producing extended-spectrum beta-lactamase (ESBL) isolated in hospitals in Brazil. Braz. J. infect. Dis., 1: 196-203, 1997.
8. GARNER, J.S.; JARVIS, W.R.; EMORI, T.G.; HORAN, T.C. & HUGHES, J.M. - CDC definitions for nosocomial infections, 1988. Amer. J. Infect. Control, 16: 128-140, 1988.
9. HARRIS, A.D.; McGREGOR, J.C.; JOHNSON, J.A. et al.- Risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria and intensive care unit admission. Emerg. infect. Dis., 13: 1144-1149, 2007. (Pubitemid 47359156)
10. HO, P.L.; CHAN, W.M.; TSANG, K.W.; WONG, S.S. & YOUNG, K. - Bacteremia caused by Escherichia coli producing extended-spectrum beta-lactamase: a case-control study of risk factors and outcomes. Scand. J. infect. Dis., 34: 567-573, 2002.
11. KANG, C.I.; KIM, S.H.; KIM, D.M. et al.- Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. Infect. Control Hosp. Epidem., 25: 860-867, 2004. (Pubitemid 40036764)
12. KAYE, K.S.; HARRIS, A.D.; SAMORE, M. & CARMELI, Y. - The case-case-control study design: addressing the limitations of risk factor studies for antimicrobial resistance. Infect. Control Hosp. Epidem., 26: 346-351, 2005.
13. KIM, B.N.; WOO, J.H.; KIM, M.N.; RYU, J. & KIM, Y.S. - Clinical implications of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteraemia. J. Hosp. Infect., 52: 99-106, 2002. (Pubitemid 38001939)
14. MARRA, A.R.; WEY, S.B.; CASTELO, A. et al. - Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence. BMC Infect. Dis., 6: 24, 2006.
15. MARTÍNEZ, J.A.; AGUILAR, J.; ALMELA, M. et al. - Prior use of carbapenems may be a significant risk factor for extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella spp. in patients with bacteraemia. J. Antimicrob. Chemother., 58: 1082-1085, 2006.
16. MARTINS, I.S.; PESSOA-SILVA, C.L.; NOUER, S.A. et al. - Endemic extended-spectrum beta-lactamase-producing Klebsiella pneumoniae at an intensive care unit: risk factors for colonization and infection. Microb. Drug Resist., 12: 50-58, 2006.
17. PANHOTRA, B.R.; SAXENA, A.K. & AL-GHAMDI, A.M. - Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae hospital acquired bacteremia. Risk factors and clinical outcome. Saudi med. J., 25: 1871-1876, 2004.
18. PATERSON, D.L.; KO, W.C.; VON GOTTBERG, A. et al. - Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. Clin. infect. Dis., 39: 31-37, 2004.
19. PATERSON, D.L. & BONOMO, R.A. - Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev., 18: 657-686, 2005.
20. PEÑA, C.; PUJOL, M.; ARDANUY, C. et al. - An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum beta-lactamase. J. Hosp. Infect., 47: 53-59, 2001.
21. RODRÍGUEZ-BAÑO, J.; NAVARRO, M.D.; ROMERO, L. et al. - Risk-factors for emerging bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Clin. Microbiol. Infect., 14: 180-183, 2008.
22. SCHWABER, M.J. & CARMELI, Y. - Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J. Antimicrob. Chemother., 60: 913-920, 2007.
23. TUMBARELLO, M.; SPANU, T.; SANGUINETTI, M. et al. - Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome. Antimicrob. Agents. Chemother., 50: 498-504, 2006. (Pubitemid 43190958)
24. ZAOUTIS, T.E.; GOYAL, M.; CHU, J.H. et al.- Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children. Pediatrics, 115: 942-949, 2005.
25. ZAVASCKI, A.P. - Assessing risk factors for acquiring antimicrobial-resistant pathogens: a time for a comparative approach. Clin. infect. Dis., 39: 871-872, 2004.
26. ZAVASCKI, A.P.; BARTH, A.L.; GASPARETO, P.B. et al. - Risk factors for nosocomial infections due to Pseudomonas aeruginosa producing metallo-beta-lactamase in two tertiary-care teaching hospitals. J. Antimicrob. Chemother., 58: 882-885, 2006.